SCNI
Scinai Immunotherapeutics
SCNI
SCNI
6 hedge funds and large institutions have $367K invested in Scinai Immunotherapeutics in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+3
Holders Change %
+100%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Citadel Advisors
Miami,
Florida
| $177K | +$177K | +306 | New |
|
|
VIA
2
Vantage Investment Advisors
State College,
Pennsylvania
| $99K | – | – | – |
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $83K | +$83K | +142 | New |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $5K | +$5K | +9 | New |
|
|
EWM
5
Edge Wealth Management
New York
| $2K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1K | +$1K | +1 | New |
|
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$44K | -120 | Closed |
|